VYTORIN | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

VYTORIN
Annual Reports

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

VYTORIN

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

131 API Suppliers, 29 USDMF, 11 JDMF, 20 EU WC, 73 KDMF, 19 NDC API, 50 Listed Suppliers, $ API Reference Price

131 API Suppliers
29 USDMF
11 JDMF
20 EU WC
73 KDMF
19 NDC API
50 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

151 Drugs in Development

151 Drugs in Development

INTERMEDIATES

31 Intermediate Suppliers

31 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

621 FDF Dossiers, 70 FDA Orange Book, 356 Europe, 20 Canada, 25 Australia, 42 South Africa, 108 Listed Dossiers

621 FDF Dossiers
70 FDA Orange Book
356 Europe
20 Canada
25 Australia
42 South Africa
108 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG, TABLET;ORAL - 10MG;10MG, TABLET;ORAL - 10MG;20MG, TABLET;ORAL - 10MG;40MG, TABLET;ORAL - 10MG;80MG

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 10MG
TABLET;ORAL - 10MG;10MG
TABLET;ORAL - 10MG;20MG
TABLET;ORAL - 10MG;40MG
TABLET;ORAL - 10MG;80MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 6 SPI Pharma, 6 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Kirsch Pharma, 1 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 19 BASF, 2 CD Formulation, 10 Corel Pharma Chem, 7 DFE Pharma, 8 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 34 Direct Compression, 32 Granulation, 22 Lubricants & Glidants, 20 Thickeners and Stabilizers, 19 Controlled & Modified Release, 12 Chewable & Orodispersible Aids, 10 Co-Processed Excipients, 10 Taste Masking, 9 Solubilizers, 8 Film Formers & Plasticizers, 7 Parenteral, 6 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Emulsifying Agents, 4 Vegetarian Capsules, 2 Topical, 1 Surfactant & Foaming Agents

51 Fillers, Diluents & Binders
42 Coating Systems & Additives
40 Disintegrants & Superdisintegrants
34 Direct Compression
32 Granulation
22 Lubricants & Glidants
20 Thickeners and Stabilizers
19 Controlled & Modified Release
12 Chewable & Orodispersible Aids
10 Co-Processed Excipients
10 Taste Masking
9 Solubilizers
8 Film Formers & Plasticizers
7 Parenteral
6 API Stability Enhancers
5 Rheology Modifiers
5 Empty Capsules
5 Coloring Agents
4 Emulsifying Agents
4 Vegetarian Capsules
2 Topical
1 Surfactant & Foaming Agents

DIGITAL CONTENT

115 News #PharmaBuzz

115 News #PharmaBuzz

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 329 Regulatory FDF Prices, 65 Annual Reports

28 US Medicaid Prescriptions
329 Regulatory FDF Prices
65 Annual Reports

MARKET PLACE

22 APIs, 5 FDF Dossiers

22 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

19 US Patents, 3 US Exclusivities, 2 Health Canada Patents

19 US Patents
3 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 4 Others

4 USP
4 Others

ANALYTICAL

6 BioAnalytical Methods

6 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,187 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

65 All

01 8Atozet

02 4Gadavist/Gadovist

03 2Gadovist product family

04 8Lipitor

05 7Nilemdo/Nustendi

06 4Rosuzet

07 16Vytorin

08 11Zetia

09 1ZetiaTM

10 4Zocor

List of Suppliers

Product Main Page

01

Brand Name : Gadovist product family

Atorvastatin, Ezetimibe

iPHEX India

Not Confirmed

Brand Name : Gadovist product family

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 466

2019 Revenue in Millions : 524

Growth (%) : -11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Zetia

Atorvastatin, Ezetimibe

iPHEX India

Not Confirmed

Brand Name : Zetia

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 482

2019 Revenue in Millions : 590

Growth (%) : -18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Atozet

Atorvastatin, Ezetimibe

iPHEX India

Not Confirmed

Brand Name : Atozet

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 453

2019 Revenue in Millions : 391

Growth (%) : 16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Vytorin

Ezetimibe, Simvastatin

iPHEX India

Not Confirmed

Brand Name : Vytorin

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 183

2019 Revenue in Millions : 285

Growth (%) : -36

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Vytorin

Atorvastatin, Ezetimibe

iPHEX India

Not Confirmed

Brand Name : Vytorin

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 183

2019 Revenue in Millions : 285

Growth (%) : -36

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Gadovist product family

Atorvastatin, Ezetimibe

iPHEX India

Not Confirmed

Brand Name : Gadovist product family

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 460

2020 Revenue in Millions : 466

Growth (%) : 9

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Zocor

Ezetimibe, Simvastatin

iPHEX India

Not Confirmed

Brand Name : Zocor

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 65

2020 Revenue in Millions : 77

Growth (%) : -16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Zetia

Atorvastatin, Ezetimibe

iPHEX India

Not Confirmed

Brand Name : Zetia

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 378

2020 Revenue in Millions : 482

Growth (%) : -22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Nilemdo/Nustendi

Bempedoic Acid, Ezetimibe, Bempedoic Acid

iPHEX India

Not Confirmed

Brand Name : Nilemdo/Nustendi

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Daiichi Sankyo

Bempedoic Acid, Ezetimibe, Bempedoic Acid

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 22

2020 Revenue in Millions : 0

Growth (%) : 100

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Vytorin

Ezetimibe, Simvastatin

iPHEX India

Not Confirmed

Brand Name : Vytorin

iPHEX India

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ezetimibe, Simvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 164

2020 Revenue in Millions : 182

Growth (%) : -10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!